Insulet reappoints Michael R. Minogue to board
PODD•Insulet appointed Michael R. Minogue to its board effective November 20, 2026. He will serve as a Class I director through the 2029 annual stockholders meeting.
1. Board appointment
Minogue previously served on Insulet’s board from August 2017 until September 2026, when he resigned to focus on his candidacy for governor of Massachusetts. He was Abiomed’s chairman, president and CEO from 2004 until its sale in December 2022.




